| abstract |
The present invention relates to a pharmaceutical combination comprising (a) a phosphoinositide 3-kinase inhibitor compound and (b) an insulin sensitivity enhancer compound for the treatment of proliferative diseases, in particular solid tumor diseases; including such combinations Pharmaceutical compositions; the use of such combinations for the preparation of drugs for treating proliferative diseases; for commercial packages or products containing such combinations as combined preparations for simultaneous, separate or sequential use It relates to a method for treating warm-blooded animals, especially humans. |